Fact CheckerSign in

NCT07249567Completed

Comparison of Patients With COPD and PRISM

Comparison of Respiratory and Peripheral Muscle Strength, Exercise Capacity, and Muscle Oxygenation in Individuals With COPD and PRISM

Source: ClinicalTrials.gov · Last updated 29 Oct 2026

Brief summary (registry, in English)

COPD is a preventable and treatable lung disease characterized by persistent and progressive airflow limitation. PRISm, on the other hand, is a spirometry pattern that does not meet COPD diagnostic criteria despite symptoms and functional impairments, but requires maintenance. PRISm can predispose to the development of COPD and exacerbations, and can reduce exercise capacity by reducing respiratory function and oxygen consumption. There are no studies in the literature comparing respiratory muscle strength, peripheral muscle strength, and oxygenation in PRISm, COPD, and healthy individuals. Therefore, this study aimed to evaluate these parameters and compare them with healthy individuals.

Status (registry)
Completed
Study type
Observational
Enrollment
91 (actual)
First submitted
18 Nov 2025
Start date
5 Oct 2025
Primary completion date
5 Mar 2026
Lead sponsor
Karabuk University
Diseases
COPD
NCT number
NCT07249567

What you commit to

  • Study type: Observational
  • Participants enrolled: 91
  • From 5 Oct 2025 to the primary completion date, 5 Mar 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Being on clinically unstable medication,

Other illness

  • Having severe orthopedic, neurological, or cardiac diseases,
  • Having a comorbid lung disease,
  • Having severe orthopedic, neurological, or cardiac diseases,
  • Having a comorbid lung disease,
  • Having a known chronic disease,

Other

  • For the COPD group:
  • Being in a COPD exacerbation,
  • Voluntarily not participating in the study.
    • For the PRISm group:
  • Being diagnosed with COPD,
  • Voluntarily not participating in the study.
    • For the healthy control group:
  • Voluntarily not participating in the study.

Who the study is looking for

  • For the COPD group:
  • Being \>40 years old,
  • Being diagnosed with COPD,
  • Being clinically stable,
  • Volunteering to participate in the study.
    • For the PRISm group:
  • Being \>40 years old,
  • Being diagnosed with PRISm,
  • Volunteering to participate in the study.
    • For the healthy control group:
  • Being \>40 years old,
  • Volunteering to participate in the study.

Age in the registry: 40 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Karabuk University, Physiotherapy and Rehabilitation Application and Research Center
Coordinator of this site? Confirm its status
KarabükTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.